Home Blog Page 2

Weebit Nano and Silvaco to Present Latest ReRAM Modeling Developments at IMW 2021


HOD HASHARON, Israel and SANTA CLARA, Calif., May 11, 2021 (GLOBE NEWSWIRE) — Weebit Nano Ltd. (ASX:WBT), a leading developer of next-generation semiconductor memory technology, and Silvaco, Inc., a leading supplier of EDA software and design IP, will jointly deliver a poster presentation on new developments in ReRAM simulation at the 13th International Memory Workshop (IMW) 2021. Sponsored by the IEEE Electron Devices Society, IMW is the premier international forum for technologists to share and learn about new developments in memory technology. The conference will be held virtually May 16 -19, 2021.

The IMW presentation is based on work described in a new paper from Silvaco, Weebit, and CEA-Leti, “A Comprehensive Oxide-Based ReRAM TCAD Model with Experimental Verification,” which explores new predictive and physics-based TCAD simulations for modeling Oxide-based ReRAM. Such simulations will help to speed the design, fabrication, and commercial adoption of ReRAM, an emerging memory technology that can meet future requirements for big data, AI, and neuromorphic computing.

In the development work, the companies leveraged the versatile applicability of the generic chemistry module in Silvaco’s Victory TCAD package, as well as a new ReRAM model validated against experimental measurements supplied by Weebit. The work goes beyond previous ReRAM modeling attempts by accounting for the impact of current compliance on the device characteristics. The presentation will be delivered by Dr. Wolfgang Goes, Software Development Engineer at Silvaco and Amir Regev, VP of Technology Development for Weebit.

For more information about IMW 2021 and to register for the virtual event, visit: https://www.ewh.ieee.org/soc/eds/imw/index.htm.

About Silvaco
Silvaco is a leading provider of TCAD, EDA software and semiconductor IP used for process and device development for advanced semiconductors, power IC, display, memory, and SoC design. For over 35 years, Silvaco has enabled its customers to develop next generation semiconductor products in the shortest time with reduced cost. The company is headquartered in Santa Clara, California and has a global presence with offices located in North America, Europe, Japan, China, Taiwan, Korea, and Singapore.

About Weebit Nano
Weebit Nano Ltd. is a leading developer of next-generation semiconductor memory technology. The company’s ground-breaking Resistive RAM (ReRAM) addresses the growing need for significantly higher performance and lower power memory solutions in a range of new electronic products such as Internet of Things (IoT) devices, smartphones, robotics, autonomous vehicles, 5G communications and artificial intelligence. Weebit’s ReRAM allows semiconductor memory elements to be significantly faster, less expensive, more reliable and more energy efficient than those using existing Flash memory solutions. Because it is based on fab-friendly materials, the technology can be quickly and easily integrated with existing flows and processes, without the need for special equipment or large investments. See: www.weebit-nano.com.

Weebit Nano and the Weebit Nano logo are trademarks or registered trademarks of Weebit Nano Ltd. in the United States and other countries. Other company, product, and service names may be trademarks or service marks of others.


Weebit Nano Investors
Eric Kuret, Market Eye
+61 417 311 335

Weebit Nano Media
Jen Bernier-Santarini
+1 650-336-4222

Farhad Hayat

Konica Minolta named a Market Leader for Managed Print Services by Quocirca


Ramsey, NJ, May 11, 2021 (GLOBE NEWSWIRE) — Konica Minolta Business Solutions U.S.A., Inc. (Konica Minolta) is pleased to announce it has been named a market leader by global market insight and research firm Quocirca, reaffirming Konica Minolta as a market leader for the scope and breadth of its portfolio in its latest ‘MPS Vendor Landscape, 2021’ report.

Managed print services (MPS) are a catalyst for digitalization, helping businesses save time and money and allowing their IT departments to focus on business-critical tasks. As a result, MPS is becoming an increasingly essential cornerstone of secure, cloud-based digital workflows that empower flexible and remote working. At the heart of this paradigm shift, Konica Minolta has helped businesses large and small transform into Intelligent Connected Workplaces.

In Quocirca’s latest ‘MPS Vendor Landscape, 2021’ report, the firm notes that Konica Minolta has an offering that is “comprehensive, spanning digital print, IoT, artificial intelligence and augmented reality solutions.” Konica Minolta’s investments, particularly in IT services “enabled it to deliver on its strategy to provide integrated IT services and become a reliable partner for digital workplaces.”

“We are extremely pleased to have been named a leader in this space by such a trusted source in the global print industry,” said Kevin Kern, Senior Vice President, Digital Transformation and Emerging Technologies. “This recognition is a testament to our efforts supporting our customers’ digital transformation through effective solutions that bring together managed print, secure IT infrastructure and leading-edge cloud services.”

Subtitled ‘Transforming the hybrid workplace,’ Quocirca’s report notes that in the wake of the COVID-19 pandemic the MPS market has become more mature, and businesses are demanding more from suppliers. With 47 percent of workers now working remotely, organizations are seeking to adapt office capacity through the use of satellite offices and flexible working. The report finds that “56 percent of organizations rank workplace services in their top three selection criteria that would make them more likely to choose a specific MPS agreement, followed by Cloud Print Services (45 percent) […] sustainability services (30 percent) and managed security services (29 percent).” 

The need for a cloud printing partner

The report describes an increase in organizations transitioning print infrastructure to the cloud to help achieve cost efficiencies: 39 percent having implemented a cloud print management platform and 37 percent intending to do so. While the majority of companies are managing print jobs on-premises, Quocirca found that three quarters of organizations expect to see greater use of cloud print management by 2025.

With regard to Konica Minolta’s offering, the report flags the customer benefits of Konica Minolta’s cloud print services, which has options for private cloud or hybrid solutions and converts an existing on-premise print environment to a cloud-based service. They offer users the flexibility of location-independent printing, while at the same time unburdening IT from the complexity of managing printers, servers, drivers, applications and network. This ensures the infrastructure is always up to date and meets the latest security standards. Customers benefit from the usual as-a-service advantages like consumption-based pricing and the ability to easily flex the solution up or down as needs change.

An integrated security approach is essential

With regard to the overarching importance of security for organizations mentioned in its report, Quocirca also noted that Konica Minolta’s scalable security services were “an integral element in all of its Intelligent Connected Workplace services and built in to all of its solutions for digital workplaces.” The company “has developed scalable solutions to meet the IT security needs of organizations of all sizes, and address a wide array of threats – from harmful email attachments to third-party intruders attempting to gain access to customer data. Additionally, Konica Minolta provides vulnerability management to assess and monitor a customer’s critical IT systems.”

Depth of MPS offering and services make a vendor a market leader

Konica Minolta’s managed print services are aligned to meet the emerging workplace needs and its requirements. As a vendor, it empowers customers with a holistic offering that includes consultancy services, hardware and software implementation, and workflow management. Quocirca categorizes market leaders, such as Konica Minolta, as vendors that have “both strategic vision and depth of service offering.” Such leaders have made “significant investments in their service portfolio and infrastructure,” which “are supported by strong delivery capabilities.” The report further explains that Konica Minolta “is taking a holistic approach that enables its solutions to be seamlessly integrated with each other to optimize customer workflows and processes – both digital and in print.”

About Konica Minolta

Konica Minolta Business Solutions U.S.A., Inc. is reshaping and revolutionizing the Workplace of the Future™. The company guides and supports its customers’ digital transformation through its expansive office technology portfolio, including IT Services (All Covered), content services, managed print services and industrial and commercial print solutions. Konica Minolta has been included on CRN’s MSP 500 list nine times and The World Technology Awards recently named the company a finalist in the IT Software category. Konica Minolta has been recognized as the #1 Brand for Customer Loyalty in the MFP Office Copier Market by Brand Keys for fourteen consecutive years, and received Keypoint Intelligence’s BLI 2021 A3 Line of The Year Award and BLI 2021-2023 Most Color Consistent A3 Brand Award for its bizhub i-Series. Konica Minolta, Inc. has been named to the Dow Jones Sustainability World Index for nine consecutive years and has spent four years on the Global 100 Most Sustainable Corporations in the World list. Konica Minolta partners with its clients to give shape to ideas and works to bring value to our society. For more information, please visit us online and follow Konica Minolta on FacebookYouTubeLinkedIn and Twitter.

# # # # #

Global Artificial Intelligence in Construction Market Expected to Generate a Revenue of $ 2,642.4 Million at a CAGR of 26.3% during the Forecast Period, 2019-2026 Exclusive Report [Pages-120] by Research Dive


New York, USA, May 11, 2021 (GLOBE NEWSWIRE) — According to a report published by Research Dive, the global artificial intelligence in construction market is anticipated to register a revenue of $2,642.4 million at a CAGR of 26.3% during the forecast period. The inclusive report provides a brief overview of the current scenario of the market including significant aspects of the market from growth factors, challenges, other market dynamics, restraints and various opportunities during the forecast period. The report also provides all the market figures making it easier and helpful for the new participants to understand the market.

Download FREE Sample Here! @ https://www.researchdive.com/download-sample/46

Dynamics of the Market

The cost-effectiveness and easy accessibility of advanced artificial intelligence products are the main factors driving the growth of the AI in construction market. The usage of AI helps companies by calculating the overhead cost and provides accurate data related to companies’ overall expenditure, which saves a lot of money for the company. Moreover, the AI devices such as robots and drones help the construction site workers by enabling them mapping and surveying and taking the perfect decision on site. This is another factor enhancing the growth of the global artificial intelligence in construction market.

One of the biggest restraining factors behind the growth of the market is the lack of technically skilled workers.  

Segments of the Market

The report has divided the market into different segments based on application and regional outlook.

Checkout How COVID-19 impacts the Artificial Intelligence in Construction Market. Click Here to Speak our Expertise before buying Report & Get More Market Insights @ https://www.researchdive.com/connect-to-analyst/46

Planning and Design Sub-Segment is Expected to Become the Most Lucrative

By application, planning and design sub-segment accounted for $134.3 million in 2018 and is further predicted to grow at a CAGR of 28.9% during the upcoming years. Planning and design is an indispensable application for the construction companies. This is the main reason behind the growth of the market segment.

North America to Dominate the Market

North America regional market recorded a revenue of $146.9 million in 2018, and is further expected to grow at a CAGR of 25.4% during the forecast period. The major attributor behind this growth is the huge population base of North American countries with high purchasing power, constant investment of the government in the automation, and initiative in artificial intelligence in the construction sector.

Request for Artificial Intelligence in Construction Market Report Customization & Get 10% Discount on this Report@ https://www.researchdive.com/request-for-customization/46

Key Players of the Market

The report mentions the key players of the global artificial intelligence in construction market which include

  1. Autodesk, Inc.,
  2. Building System Planning, Inc.
  3. Smartvid.io, Inc.
  4. Komatsu Ltd
  5. NVIDIA Corporation
  6. Doxel Inc.
  7. Volvo AB
  8. Dassault Systemes SE among others.

These players are focusing on research and development, product launches, collaborations and partnerships to sustain the growth of the market. For instance, in November 2020, Dassault Systèmes announced jointly with NuoDB, that Dassault Systèmes, which already had a 16% ownership interest, is acquiring the remainder of NuoDB equity.

Based in Cambridge, Massachusetts, NuoDB provides a cloud-native distributed SQL database that capitalizes on the competitive advantages of the cloud, with on demand scalability, continuous availability and transactional consistency, and is built for mission critical applications. 

The report also summarizes many important aspects including financial performance of the key players, SWOT analysis, product portfolio, and latest strategic developments.

In Addition, the report having some numorus point about the leading Business Manufactures, Like, SWOT analysis, Product Portfolio, Finanical Status – Inquire to Get access for Detailed Top Companies Development Strategy Report


Cemtrex Receives $0.4 Million Development Order in Virtual Reality Segment


Brooklyn, NY, May 11, 2021 (GLOBE NEWSWIRE) — — Cemtrex Inc. (NASDAQ: CETX, CETXP, CETXW), a technology company driving innovation in Internet of Things (IoT), security, machine vision & artificial intelligence, and augmented & virtual reality, has received a $400,000 new customer order for the development of a Virtual Reality application for a Nevada-based pain management and relief institution.

The Virtual Reality application will be implemented as part of the customer’s state-of-the art VR pain relief program.

“This new customer order reaffirms that Cemtrex’s VR technology is at the forefront of innovation and ever-increasing applications,” said Saagar Govil, Chairman and CEO of Cemtrex. “The market for virtual reality applications continues gaining momentum with double-digit compound annual growth rates into the foreseeable future and global VR spending to surpass $120 annually by 2026 according to some reports. Our expanding presence in the AR & VR space positions us to take advantage of that demand across multiple industries now and in the future. VR training solutions will be key focus area of growth for our Company.”

“The medical industry, in particular, is primed for disruption amid increasing pressure to become more efficient on an economic basis with applications ranging from training healthcare professionals to telemedicine and remote surgery expected to reach over $4 billion in value in the North American market alone in just the next four years,” continued Mr. Govil.

The new order will be executed this quarter. The details of the customer were not provided due to confidentiality agreements in place.

About Cemtrex

Cemtrex, Inc. (CETX) is a leading multi-industry technology company that is driving innovation in markets such as Internet of Things (IoT), Augmented and Virtual Reality (AR & VR), and Artificial Intelligence and Computer Vision (AI & CV) in a wide range of sectors, including consumer products, industrial manufacturing, digital applications, and intelligent security & surveillance systems.


Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, including statements relating to the closing of the offering, gross proceeds from the offering, our new product offerings, expected use of proceeds, or any proposed fundraising activities.  These forward-looking statements are based on management’s current expectations and are subject to certain risks and uncertainties that could cause actual results to differ materially from those set forth in or implied by such forward looking statements.  Statements made herein are as of the date of this press release and should not be relied upon as of any subsequent date. These risks and uncertainties are discussed under the heading “Risk Factors” contained in our Form 10-K filed with the Securities and Exchange Commission.  All information in this press release is as of the date of the release and we undertake no duty to update this information unless required by law.

CINECA and D-Wave Expand Access to Quantum Computing Technology and Resources in Italy


BOLOGNA, Italy and BURNABY, British Columbia, May 11, 2021 (GLOBE NEWSWIRE) — CINECA, the Italian inter-university consortium and one of the world’s leading global supercomputing centers, and D-Wave Systems Inc., the leader in quantum computing systems, software, and services, today announced a formal collaboration to offer Italian universities, researchers, and developers expanded access to practical quantum computing technology and resources through D-Wave’s Leap™ quantum cloud service.

CINECA, which is made up of 69 Italian universities, 25 national research institutions, the Ministry of Education, and the Ministry of Universities and Research, will benefit from expanded, real-time access to the Leap quantum cloud service. This access includes D-Wave’s hybrid quantum/classical solvers, which leverage both quantum solutions and best-in-class classical algorithms to run large-scale business-critical problems. With real-time access to quantum computers via the cloud, the Italian and international scientific community have the opportunity to further quantum education, publication, and R&D, while boosting the development of real-world quantum applications.

This collaboration aids the consortium’s mission to support Italy’s scientific community and improve quantum computing literacy and skills training for university partners. This, in turn, will benefit the larger public administration and private enterprise ecosystem. CINECA university members, such as the Polytechnic University of Milan, have already expressed interest in leveraging quantum computing to explore drug repurposing and development, natural disaster response and relief, and sustainability challenges such as decarbonization and energy production. As an example of the value of the collaboration, D-Wave and CINECA hosted a joint webinar on March 31st showcasing CINECA’s work on molecular docking for drug discovery utilizing D-Wave’s quantum system.

D-Wave will also provide cloud access via Leap to its latest generation quantum system, Advantage, which includes:

  • Updated Topology: The topology in Advantage makes it the most connected of any commercial quantum system in the world. In the Advantage system, each qubit may connect to 15 other qubits, enabling the embedding of larger, more complex problems.
  • Increased Qubit Count: Advantage includes more than 5,000 qubits. More qubits and richer connectivity provide quantum programmers access to a larger, denser, and more powerful graph for building commercial quantum applications.
  • Greater Performance & Problem Size: With the capacity to solve problems with up to 1 million variables, the hybrid solver service in Leap allows researchers to run large-scale, business-critical problems, expanding the complexity and more than doubling the size of problems that can run directly on the quantum processing unit (QPU).
  • Expansion of Hybrid Software & Tools in Leap: The hybrid solver service, new solver classes, ease-of-use, automation, and new tools provide an even more powerful hybrid rapid development environment in Python for business-scale problems.
  • Ongoing Releases: D-Wave continues to bring innovations to market with additional hybrid solvers, QPUs, and software updates through the cloud. Users can get started today with Advantage and the hybrid solver service, and will benefit from new components of the platform through Leap as they become available.

“We have enjoyed a long-standing relationship with the pioneering team at CINECA, which was one of the first non-profit consortiums to explore quantum computing with us,” said Daniel Ley,  SVP Global Sales, D-Wave. “Bringing quantum computing to the world requires more than just vendors alone. We need to continue to build a robust ecosystem of developers and researchers, innovative scientific institutions, cutting-edge academic organizations, and forward-thinking businesses to work together. CINECA is aligned with us in that mission and committed to helping their ecosystem build practical and applied quantum computing applications.”

“At CINECA we are very happy to be part of this agreement with D-Wave. Quantum computing is a field that has been strongly emerging in recent years,” said Sanzio Bassini, Head of the HPC Department at CINECA. “Its natural association with HPC, which CINECA has been dealing with for more than 50 years, makes the issue of high interest both for CINECA and for the entire ecosystem of universities and research institutions that it represents. Thanks to D-Wave for the collaboration. I have no doubt that it will be a wonderful experience for both parties.”

“Thanks to the quantum team at CINECA we were able to start addressing part of our molecular docking problem using D-Wave’s system,” said Gianluca Palermo, Associate Professor at the Polytechnic University of Milan. “They supported us in the problem formulation such that it was manageable by the quantum solver, and in its deployment on the quantum machine. This is the key to educating a team with no prior experience and helping them evaluate the endless possibilities offered by quantum systems.”

To learn more about how CINECA and D-Wave are working together to expand access to quantum computing technology and resources in Italy click here. To find out more about CINECA’s work in molecular docking for drug discovery utilizing D-Wave’s quantum systems, click here.

CINECA established in 1969, is a not-for-profit consortium of 69 Italian Universities 25 national research institutions, the Italian Ministry of Education, and the Italian Ministry of Universities and Research. CINECA is the Italian national facility for supercomputing applications and research, one of the largest in Europe. It develops advanced Information Technology applications and services supporting the European scientific communities, the Italian academic administration offices, the Italian Ministry of Education, the Italian Ministry of Universities and Research, and the world of industry and Public Administration.

CINECA’s HPC infrastructure is equipped with cutting-edge technology managed by qualified personnel, which cooperates with researchers and customers for the most effective exploitation of the HPC systems, in both the academic and industrial fields. The mission of CINECA is to accelerate the scientific discovery by providing high performance computing resources, data management and storage systems and tools, HPC services and expertise at large. CINECA represents Italy in PRACE (the pan-European ESFRI e-infrastructure for HPC) and in the EuroHPC Joint Undertaking (a joint initiative between the EU, European countries and private partners to develop a World Class Supercomputing Ecosystem in Europe).

About D-Wave Systems Inc.
D-Wave is the leader in the development and delivery of quantum computing systems, software and services and is the world’s first commercial supplier of quantum computers. Our mission is to unlock the power of quantum computing for the world. We do this by delivering customer value with practical quantum applications for problems as diverse as logistics, artificial intelligence, materials sciences, drug discovery, scheduling, cybersecurity, fault detection, and financial modeling. D-Wave’s systems are being used by some of the world’s most advanced organizations, including NEC, Volkswagen, DENSO, Lockheed Martin, USRA, USC, and Los Alamos National Laboratory. With headquarters near Vancouver, Canada, D-Wave’s US operations are based in Palo Alto, CA. D-Wave has a blue-chip investor base including PSP Investments, Goldman Sachs, BDC Capital, NEC Corp., and In-Q-Tel. For more information, visit: www.dwavesys.com.

D-Wave Systems Inc.

Alberta Project Explores Use of Synthetic Data as Alternative to Health Data Utilization


EDMONTON, Alberta, May 11, 2021 (GLOBE NEWSWIRE) — Health City and the Institute of Health Economics (IHE) are pleased to welcome Merck Canada as a new partner to an innovative Alberta collaboration aimed at exploring the potential uses for synthetic health data. Merck Canada will be joining existing partners Alberta Innovates and the University of Alberta, and will support the acceleration of research in the field of synthetic data use with the ultimate goal of helping improve health outcomes for Canadians.

Synthetic data accurately simulates patient-derived datasets and, although generated from real world data, is not linked to the individuals from whom the data were derived. Synthetic datasets can be shared freely among innovators and researchers without raising patient privacy concerns or contravening the Alberta Health Information Act because the data contains no real patient health information, an important distinction.

The collaborating partners engaged the Office of the Information and Privacy Commissioner of Alberta (OIPC) to ensure synthetic data can be used in a way that respects the privacy of citizens.

“We believe the ability to quickly generate high-quality synthetic data will be a game changer for clinical trials and will provide for multiple uses in artificial intelligence & machine learning,” said Tim Murphy, VP Health, Alberta Innovates. “It also has the potential to grow our economy and knowledge industries.”

The first phase of the project, which took place in October 2020, validated the first synthetic health dataset in Alberta. The success of Phase I informed the current phase, which aims to establish use cases for the synthetic datasets. Validating synthetic datasets and establishing use cases creates further opportunities for innovators to work alongside the health system while preserving patient privacy. Creating opportunities for innovators and researchers is a vital step in attracting investment to the province.

“We are very pleased to support Alberta’s innovators and be part of this exciting collaboration to accelerate research in the field of synthetic data use,” said Heidi Waser, Executive Director, Patient Access at Merck Canada. “It is by working together through innovative collaborations such as this one that we will help facilitate access to health information critical to scientific advancement, ultimately helping improve Canadian health outcomes.”

“Synthetic data is a promising way to address the challenges of using personal health data directly and we are pleased that Merck Canada has joined this exciting project,” stated Dr. Chris McCabe, CEO at IHE. “We need now to move from theory to actually testing the approach on some practical use cases coming from innovator and researcher questions.”

Merck Canada’s involvement in the project marks the first occasion a multinational corporation has invested in a synthetic data project in Alberta.

“This is an exciting development for health innovation. Establishing the ability to freely access and share health datasets while preserving patient privacy will drive improved health outcomes and economic growth for Alberta. Eliminating barriers to information sharing will attract the attention of multinationals corporations to the province,” said Reg Joseph, CEO at Health City. “Merck Canada’s involvement in the project is a glimpse at what synthetic data could mean for Alberta’s innovation sector.”

About Health City

Health City is a Canadian not-for-profit Corporation that works with clinicians, innovators, philanthropic organizations, and companies to develop new pathways of care that can drive better health outcomes and economic development in the health sector. Our focus is on transforming innovations from our health sector into solutions that have commercial application and global relevance, adopting them for impact locally and scaling them for export to global markets.

For more information, visit www.healthcities.ca

About Institute of Health Economics

Institute of Health Economics (IHE) is a not-for-profit health research organization providing expertise to provincial and national stakeholders from the public and private sectors in evidence production, synthesis and application; economic analysis; and policy engagement. It was founded in 1995 on the belief that the best solutions to healthcare problems are the result of a collaborative approach, with all stakeholders at the table sharing insights and information in support of improved health outcomes and a thriving economy.

For more information, visit www.ihe.ca

About Merck Canada

For more than 130 years, Merck, known as MSD outside of the United States and Canada, has been inventing for life, bringing forward medicines and vaccines for many of the world’s most challenging diseases in pursuit of our mission to save and improve lives. We demonstrate our commitment to patients and population health by increasing access to health care through far-reaching policies, programs and partnerships. Today, Merck continues to be at the forefront of research to prevent and treat diseases that threaten people and animals – including cancer, infectious diseases such as HIV and Ebola, and emerging animal diseases – as we aspire to be the premier research-intensive biopharmaceutical company in the world. For more information about our operations in Canada, visit www.merck.ca and connect with us on YouTube and Twitter @MerckCanada

About Alberta Innovates

Alberta Innovates invests in research, innovation and entrepreneurship to drive provincial economic growth and diversity. We ignite the power of innovation through our work with researchers, industry and entrepreneurs to move Alberta to a lower-carbon future, promote the responsible use of land and water, and contribute to the improved health and well-being of Albertans. 
Alberta Innovates provides technical expertise, entrepreneurial advice and support, opportunities for partnerships, and funding to advance the best ideas. We support a broad range of research and innovation activity – from discovery to use. Collaboration is at the heart of what we do – bringing together bright minds and great ideas. 
Find out how Alberta innovates: albertainnovates.ca

Media Inquiries:

Health City
Stephanie Gillis-Paulgaard
Email: media@healthcities.ca
Phone: 780-628-3101

Alberta Innovates
Dwayne Brunner
Email: dwayne.brunner@albertainnovates.ca
Phone: 587-572-4091

mPhase Technologies Inc. Announces $3 Million Financing


– Funds Expected to Accelerate the Company’s Near-Term Growth Initiatives

Gaithersburg, MD, May 11, 2021 (GLOBE NEWSWIRE) — mPhase Technologies, Inc. (OTC: XDSL) (“mPhase” or the “Company”), a leading technology driven development company that creates and commercializes solutions that impact everyday people, today announced it has entered into a Securities Purchase Agreement with two accredited investors raising over $3 million for the company.

Per the terms of the agreement, the capital was raised via a convertible promissory note with a fixed conversion price of $0.20 per share with two new accredited investors. The note matures on May 5, 2022 and bears interest at the rate of 5% per annum. Full terms of the note are available in the Company’s Form 8-K dated May 11, 2021 as filed with the SEC.

Anshu Bhatnagar, Chief Executive Officer of mPhase commented, “The investors who participated in this round are our first institutional investors. The note was specifically crafted so that it should not, in our view, impede a future listing to a national securities exchange. The note includes provisions for a forced conversion upon a Qualified Uplist with up to 90% of the related shares subject to a 180-day lock up period after the Company’s listing on a national exchange. We are very pleased to have our first strategic institutional investors as we embark on what we believe will be a transformative growth stage for our company.

The additional capital will ensure a rapid start to the current multi-year plan, which includes creating a consumer engagement ecosystem that is gaining traction with potential partners in retail, transportation and government.”

About mPhase Technologies

mPhase is a technology driven, innovative development company that creates and commercializes products and applications that impact everyday people. The Company is assembling industry-leading teams specializing in artificial intelligence, machine learning, software, consumer engagement, and other advanced technologies. Additional information can be found at the mPhase website, www.mphasetech.com. Please follow us on twitter: @mPhase_Tech for the latest updates.

Safe Harbor Statement

This press release contains certain forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements are identified by the use of the words “could,” “believe,” “anticipate,” “intend,” “estimate,” “expect,” “may,” “continue,” “predict,” “potential,” “project” and similar expressions that are intended to identify forward-looking statements. All forward-looking statements speak only as of the date of this press release. You should not place undue reliance on these forward-looking statements. Although we believe that our plans, objectives, expectations and intentions reflected in or suggested by the forward-looking statements are reasonable, we can give no assurance that these plans, objectives, expectations or intentions will be achieved. Forward-looking statements involve significant risks and uncertainties (some of which are beyond our control) and assumptions that could cause actual results to differ materially from historical experience and present expectations or projections. Actual results to differ materially from those in the forward-looking statements and the trading price for our common stock may fluctuate significantly. Forward-looking statements also are affected by the risk factors described in the Company’s filings with the U.S. Securities and Exchange Commission. Except as required by law, we undertake no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events.

Company Contact

Investor Contact
Brian M. Prenoveau, CFA
MZ Group – MZ North America

AI Fintech Firm Riskfuel Expands into Insurance Space


TORONTO, May 11, 2021 (GLOBE NEWSWIRE) — Riskfuel has been selected to take part in gener8tor’s OnRamp Insurance Accelerator in partnership with Allianz Life and Securian Financial. Riskfuel is one of five startups chosen from over 500 applicants to participate in gener8tor’s three-month, concierge accelerator program. The exclusive program offers startups financing and exposure to global innovative insurance firms.

“We are thrilled to join the OnRamp Accelerator program,” says Ivan Sergienko, Chief Product Officer at Riskfuel. “There is no better way for Riskfuel to learn how to tailor our products to serve the insurance industry than by working together with the teams at Securian Financial and Allianz Life.”

Riskfuel employs artificial intelligence techniques to produce ultra-fast versions of the proprietary software that banks and insurance companies use to value and risk manage their portfolios of financial instruments, delivering both new business opportunities and significant reductions in operating costs. In collaboration with Microsoft and Scotiabank, Riskfuel’s technology was shown to accelerate production workloads by more than 20 million times.

“Firms must run these slow computational models hundreds of millions of times per day, so they incur huge compute costs,” explains Riskfuel CEO Ryan Ferguson. “And by accelerating their models a million-fold, Riskfuel saves them tons of money, which they can put towards building new tools or innovating new products.”

Over recent months, the Toronto-based Riskfuel has attracted several global industry awards for its technology. Riskfuel was awarded Best Sell-Side Newcomer – Trading, Pricing and Analytics by leading financial market technology information provider WatersTechnology, and Innovator of the Year by the Futures Industry Association (FIA). Additionally, a project with Scotiabank was awarded Technology Innovation of the Year by top capital markets publication Risk.net.

Ferguson sees the expansion into insurance as a natural step for Riskfuel. “The models used in the insurance industry are very similar to ones we have already had great success in accelerating for capital markets use cases. Additionally, with the looming accounting changes, such as IFRS17, insurance companies are looking for ways to manage their increasing computational requirements.”

About the OnRamp Insurance Accelerator:

Each year, the OnRamp Insurance Accelerator, with Allianz Life and Securian Financial, invests in five insurtech startups who participate in a three-month, concierge accelerator program in Minneapolis-St. Paul. Each startup receives a cash investment of $100,000, mentorship from teams within Securian Financial and Allianz Life, and access to gener8tor’s global network of mentors and investors.

Learn more at www.OnRampInsurance.com.

About Riskfuel:

Riskfuel builds AI solutions to accelerate valuation and risk sensitivity calculations. Founded in 2019 by capital markets experts, the company provides valuation solutions to banks and insurance companies in North America and Europe with use cases covering XVA, Risk, and Front Office analytics.

For more information about Riskfuel, visit our website or connect with us on LinkedIn.

InveniAI Appoints Industry Leader Dr. Salvatore Alesci as Chief Scientific Officer to Advance AI-Powered Portfolio of Assets Targeting Dysregulation of the Gut-Brain Axis

  • Pipeline to include new chemical entities as well as re-innovated drugs, all targeting dysregulation of the gut-brain axis and inflammasome pathways for chronic inflammatory diseases
  • Dr. Alesci’s proven track record in optimizing early-stage drug development of multiple programs in various therapeutic areas will be key as the company leverages its AI-platform to advance and diversify its portfolio

GUILFORD, Conn., May 11, 2021 (GLOBE NEWSWIRE) — InveniAI® LLC, a global leader in pioneering the application of artificial intelligence (AI) and machine learning (ML) to transform innovation across drug discovery and development, announced today the appointment of Salvatore (Salvo) Alesci, M.D., Ph.D., as its Chief Scientific Officer. Dr. Alesci, a physician-scientist, R&D strategist, and science policy influencer with expertise in translational medicine, will be responsible for advancing programs from IND-enabling to human proof-of-concept studies and working with the leadership team on scientific and business strategies. The company’s AI-driven pipeline currently has three programs prioritized for development that address the intersection of the Gut-Brain Axis (GBA) and chronic inflammatory diseases of the gastrointestinal (GI) tract.

For every ten adults in the world, four suffer from functional GI disorders of varying severity. Two-thirds of these people will have chronic, fluctuating symptoms1. While the pathophysiology of functional GI disorders is multifaceted, it is known that bidirectional dysregulation of the GBA, including altered mucosal immune function, visceral hypersensitivity, and abnormal gastrointestinal motility plays a key role in these disorders1. InveniAI harnesses its AI platform AlphaMeld® to deconvolute the complex network of GBA pathways and generate hypotheses across the entire spectrum of pathophysiological processes involved in inflammatory gut diseases, from induction to early mucosal damage and fibrosis. AlphaMeld® has already helped identify drug candidates with demonstrated safety. Initial programs will target the potential treatment of irritable bowel syndrome (IBS), inflammatory bowel disease (IBD), and rare gastrointestinal disorders, with the first NDA filing projected for 2025.

Dr. Krishnan Nandabalan, Ph.D., Founder, President, and CEO, InveniAI, said, “I’m delighted to have Salvo join the InveniAI team during this next phase of growth. I’m looking forward to working closely with him as we rapidly advance our portfolio of therapies for chronic inflammatory GI-diseases, with plans to scale these efforts in the near term. As a highly accomplished and proven leader, Salvo brings with him a breadth of knowledge in running drug discovery programs at the pre-clinical and clinical level and is a proponent of innovative approaches to biopharmaceutical discovery and development.”

“InveniAI’s vision of leveraging AI to deconvolute and de-risk drug discovery and development is particularly exciting to me, as I strive to progress and bring novel medicines to patients in need,” said Salvatore Alesci, M.D., Ph.D. CSO, InveniAI “I’m thrilled to join an outstanding team in deploying cutting-edge AI-technology to decode the GBA and address a multitude of highly debilitating chronic diseases, such as IBS and IBD, that remain without optimal therapeutic options,” he added.

Dr. Alesci is a highly regarded healthcare executive with over two decades of experience spanning multiple scientific leadership roles in the government, pharmaceutical and non-profit sectors. He currently serves as Chief Scientist and Strategy Officer for Beyond Celiac – the leading science-driven patient advocacy organization in the U.S. focused on accelerating the development of treatments and a cure for celiac disease, a condition that among others affects his daughter, which has been an important driver of his interest in the GBA. Dr. Alesci was most recently V.P. and Head of R&D Global Patient and Scientific Affairs at Takeda Pharmaceuticals, where he enabled effective partnering between the company and patients organizations throughout the drug life-cycle, ensuring early and continued access to medicines. He has served in several Translational Medicine leadership roles at Wyeth, Pfizer, and Merck, overseeing large and diverse drug portfolios spanning multiple therapeutic areas, including musculoskeletal biology, immunology, and rheumatology. Dr. Alesci received his M.D. (cum laude) and a Ph.D. in Experimental Endocrine and Metabolic Sciences from the University of Messina, School of Medicine (Italy) and completed a Research Fellowship in Rheumatology, Immunology, and Allergy at Georgetown University. After his postgraduate training, Dr. Alesci spent almost a decade conducting cutting-edge basic and translational research on the interplay between the neuroendocrine and immune systems at the National Institutes of Health (NIH). He has published extensively and received multiple recognitions for his research excellence, including two Special Acts of Service Awards by the U.S. Department of Health and Human Services.

About AlphaMeld®
AlphaMeld® is an AI-based platform powered by machine learning algorithms. The platform accelerates innovation by identifying alpha signals for targets, drugs, and healthcare products and technologies. Primed with data sets that have been cleaned, curated, and connected for over a decade, the platform generates testable hypotheses based on an ideal mode of pharmacotherapy (antibody, protein replacement, siRNA, mRNA, small molecule, cell and gene therapy, and gene-editing modalities), disease severity, gene ontology, disease pathways, proteinopathies, standard of care, emerging innovation, and enabling technologies while factoring in medical, scientific, strategic, and commercial considerations. AlphaMeld® operates in real-time and in a rapidly changing and diverse data environment.

About InveniAI®
InveniAI® LLC, based in Guilford, Conn., is a global leader pioneering the application of artificial intelligence (AI) and machine learning (ML) to transform innovation across drug discovery and development by identifying and accelerating transformative therapies for diseases with unmet medical needs. The company leverages, AlphaMeld®, an AI- and ML-powered platform, to harness petabytes of disparate data sets to recognize and unlock value for drug discovery and development. Numerous industry collaborations in Big Pharma, Specialty Pharma, Biotech, and Consumer Healthcare showcase the value of leveraging our technology to meld human experience and expertise with the power of machines to augment R&D decision-making across all major therapeutic areas. The company leverages AlphaMeld® to augment and accelerate drug discovery programs for our industry partners. For more information, please visit www.inveniai.com.

1. Functional gastrointestinal disorders: advances in understanding and management

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/b3baacb2-132d-4ead-b7d0-c935c0ec6745

Anita Ganjoo
InveniAI LLC
Corporate Communications
T: +1 203 643 8041
E-mail: aganjoo@inveniai.com 

Bridge Monitoring System Market is anticipated to grow around 13% annually through the period of 2021 to 2031 – Persistence Market Research



Governments of different countries are focusing on sustainability of structures and spending millions of dollars on bridge monitoring systems. Thus, high capital investments in bridge monitoring systems by governments is anticipated to be a major factor driving market growth over the coming years.

Due to loss of lives and capital from catastrophic failure of infrastructure in recent years, high capital investment in structural health monitoring is resulting in superior benefits for transportation. Costly repairs and minimizing downtime for the lifetime of a new bridge can be avoided with the help of one-time high capital investment in structural health monitoring across various industries.

The global bridge monitoring system market is anticipated to grow around 13% annually through the period of 2021 to 2031, as there has been an increase in high capital investments in bridge monitoring systems in the past years.

Key Takeaways from Market Study

  • Several infrastructural companies and governments are adopting bridge monitoring technologies to reduce expenses involved in dealing with infrastructural repairs, and this is creating new opportunities for vendors.
  • Easy accessibility and maintenance through wireless technology and wide availability of software after deployment over cloud are expected to support growth of the wireless segment throughout the forecast period.
  • The United States was the dominant country in 2020 in terms of value for bridge monitoring systems. Over the coming years, the United Kingdom is expected to be one of the key markets for sustainable revenue generation from bridge monitoring systems, owing to increasing adoption of advanced and wireless technologies in this country.
  • The European region is expected to remain a key market for bridge monitoring systems and solutions, as increasing investments in smart city development in the region is anticipated to create lucrative opportunities for stakeholders.

Request for sample PDF of report: https://www.persistencemarketresearch.com/samples/24487

“Many key players are focusing on developing cost-efficient bridge monitoring solutions in which electrical, magnetic, thermal, and other physical variables, chemical variables, and several technologies are integrated to offer more accurate results, which is likely to increase adoption of integrated bridge monitoring systems,” says a Persistence Market Research analyst.

COVID-19 Pandemic Impact Analysis

The bridge monitoring system market experienced a decline in growth in the first three quarters of 2020, owing to the severe impact on the construction industry during the COVID-19 pandemic outbreak. Depending on the severity of the public health crisis, as well as the timing and strictness of confinement measures, lockdowns impacting the construction sector have varied widely by location and project type, and containment measures involved total or partial shutdowns of construction sites.

Know the methodology of report by asking an expert: https://www.persistencemarketresearch.com/ask-an-expert/24487

Companies providing bridge monitoring systems have witnessed decrease in demand for monitoring devices due to the COVID-19 pandemic. Major companies operating in the market have been negatively impacted during the first half of 2020.However, the trend toward the automation of processes along with remote working solutions has been increasing since the start of 2021.Standardization and automation of maintenance and repair is expected to increase gradually. Thus, the market is anticipated to gain back its momentum by the second half of 2021.

Get full access of report: https://www.persistencemarketresearch.com/checkout/24487 

Find More Valuable Insights

Persistence Market Research puts forward an unbiased analysis of the global market for bridge monitoring systems, providing historical demand data (2016-2020) and forecast statistics for the period 2021-2031. To understand the opportunities in the market,it has segmented on the basis of component (hardware, structural health monitoring software, and services), technology (wired and wireless), and application (railway bridges and road bridges/overpasses), across seven major regions of the world.

Browse Research Release at: https://www.persistencemarketresearch.com/market-reports.asp

Browse End-to-end Market: IT and Telecommunication

Related Reports: